Global Lung Cancer Diagnostics Market Size & Outlook

The lung cancer diagnostics industry worldwide is expected to reach a projected revenue of US$ 18,145.4 million by 2030. A compound annual growth rate of 8.5% is expected of the worldwide lung cancer diagnostics industry from 2024 to 2030.
Revenue, 2023 (US$M)
$10,276.6
Forecast, 2030 (US$M)
$18,145.4
CAGR, 2024 - 2030
8.5%
Report Coverage
Worldwide

Global lung cancer diagnostics market highlights

  • The global lung cancer diagnostics market generated a revenue of USD 10,276.6 million in 2023 and is expected to reach USD 18,145.4 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 8.5% by 2030.
  • In terms of segment, outpatient facilities accounted for a revenue of USD 6,297.7 million in 2023.
  • Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 10,276.6 million
Market revenue in 2030USD 18,145.4 million
Growth rate8.5% (CAGR from 2023 to 2030)
Largest segmentOutpatient facilities
Fastest growing segmentHome Care
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHospitals, Outpatient Facilities, Home Care, Research & Manufacturing

Other key industry trends

  • In terms of revenue, the North America accounted for 47.3% of the global lung cancer diagnostics market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Japan is the fastest growing regional market and is projected to reach USD 820.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Lung Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website

Global lung cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lung cancer diagnostics market will help companies and investors design strategic landscapes.


outpatient facilities was the largest segment with a revenue share of 61.28% in 2023. Horizon Databook has segmented the Global lung cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Lung Cancer Diagnostics End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals
    • Outpatient Facilities
    • Home Care
    • Research & Manufacturing

Reasons to subscribe to Global lung cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global lung cancer diagnostics market databook

  • Our clientele includes a mix of lung cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global lung cancer diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global lung cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global lung cancer diagnostics market statistics, by region, 2018-2030 (US$M)

Top 10 countries by Lung Cancer Diagnostics Market revenue, 2023 (USD Million)

Top 10 countries by Lung Cancer Diagnostics Market revenue, 2023 (USD Million)

Global lung cancer diagnostics market, by region, 2023 (US$M)

Global lung cancer diagnostics market statistics, by region, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more